Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
35 Cards in this Set
- Front
- Back
Prevertebral vs Paravertebral sympathetic ganglia:
WTF? |
Paravertebral run along the spinal cord; Prevertebral are located elsewhere (i.e. mesenteric ganglion)
therefore, prevertebral ganglions will have longer preganglionic sympa fibers |
|
origin of parasympathetic fibers
|
Cranial nerves 3,7,9,10
Sacral Cord (S2-S4) -lower GI, bladder, sex organs, genitalia |
|
explain what's funny about sweat glands
|
Sympathetic innervation with ACh used at the effector synapse; the ACh receptor is muscarinic (same AChR @ PS effector synapse)
|
|
Neuromuscular J(x)
PS Effector J(x) Autonomic Ganglia Sweat Glands Two of them use muscarinic receptors; two of them use nicotnic receptors. Which are which? |
Sweat/PS effector = M
NMJ/autonomic gang. = N |
|
Clinical use of systemic ACh agonists and antagonists...?
|
ACh Agonists = too many side effects
ACh antagonists = many clinical uses, including anti-hypertensives |
|
enzyme that produces ACh
|
CAT (cholineacetyl transferase)
|
|
vasculature
eyes heart salivary glands sweat glands GI Which organs are dominated by sympathetic drive? Which by PS drive? How can one simultaneously inhibit the dominant drive to each of these systems? |
vasculature: S
eyes: PS heart: PS (S with pathology) salivary glands: PS sweat glands: S (but uses Muscarinic ACh receptor) GI: PS -Give anti-ACh (nicotinic) that affects autonomic ganglia (S + PS inhibition) |
|
G/U contraction
salivation/sweating eye gastric secretion Assume a steady dose of anti-cholinergic drug is given: rank the aforementioned systems according to when they would first feel the effects of the drug. |
(most sensitive to least)
1. secretions/sweating 2. eye 3. G/U contraction 4. Gastric secretion |
|
name some clinical applications of anti-cholinergics acting at the level of the CNS
|
Parkinson's
Motion sickness Sedation Anti-depressants (tricyclines) |
|
When anti-cholinergics are given, why would sweating decrease?
|
Sweating = sympathetic terminals releasing ACh onto muscarinic receptors; anti-cholinergics will block M receptors
|
|
AChEsterase Inhibitor is the antidote for someone suffering hallucination, circulatory collapse, ataxia, and dryness.
What got the person into trouble in the first place? |
Systemic block of ACh @ M receptors (anti-cholinergic poisoning)
|
|
Describe the role of anti-cholinergics in myasthenia gravis treatment
|
in MG, AChEi is given to increase [ACh] @ the NMJ; in order to prevent systemic [ACh] increase (and PS overdrive) in the body, anti-cholinergics are given
|
|
How could anti-cholinergics help the following organs (list a pathology for each)?
lungs heart urinary nose |
lungs - bronchospasm
heart - bradyarrythmia urinary - urgency incontinence nose - rhinitis / runny nose |
|
the classic muscarinic agonist: b_______
Describe it's application in OAGlaucoma and xerostomia treatment. |
the classic muscarinic agonist: _bethanicol_
OAGlaucoma: contract ciliary muscle, open Schlemm's canal, decrease IOP Xerostomia: fixes dry mouth after H/N surgery |
|
renin secretion, pineal gland effects, uterine relaxation, increased conduction velocity of the heart
all of these are results of ________ stimulation |
adrenergic stimulation
(muscle relaxation, renin = BP rise) |
|
Classic Agonist/Antagonists for Sympathetic Receptors (A and B, not including subtypes)
|
A agonist: phenylephrine
A antagonist: phentolamine B agonist: isoproterenol B antagonist: proterenol this probably isn't important |
|
selectivity vs specificity in beta agonists (and antagonists): WTF?
|
specific implies exclusive action; selective means drug acts at both sites, but far stronger at one site
|
|
Beta1/2 (ant)agonists...name 'em
|
B1 agonist: dobutamine
B1 antagonist: atenol B2 agonist: terbutalmine B2 antagonist: butoxamine |
|
Epinephrine is released at a 1:X ration to norepinephrine. This is a good thing, b/c EPI acts at _______
|
1:4 ratio
EPI acts at B1 and B2 receptors (NE only acts at B1, which consists of heart/renal pretty much) |
|
experiment: NE decreases pulse rate; EPI increases pulse rate. Explain.
|
NE acts equally @ heart and vasculature: TPR/diastolicBP increase-> baro reflex lowers pulse via PS output
EPI acts stronger @ B than A; TPR falls, but pulse pressure increases; vessel dilation in the muscles (B) overrides arteriole constriction (A) |
|
How does sympathetic drive inhibit the gut (alpha and beta mechanisms)?
|
Alpha receptors @ PS nerve terminals inhibits ACh release
Beta receptors @ gut muscle causes relaxation |
|
NE and phentolamine are non-selective agonists and antagonists, respectively, for alpha receptors. Name the following selective drugs:
alpha 1 agonist: alpha 1 antagonist: alpha 2 agonist: |
alpha 1 agonist: methoxamine
alpha 1 antagonist: prozacin alpha 2 agonist: a-CH3-NE |
|
illustrate the utility of a selective alpha 1 blocker with an example involving an anti-hypertensive drug
|
non-selective alpha-blocker will also block alpha 2, which is critical in shutting off the sympathetic response (inhibits NE release); extra NE results in B1 stimulation of the heart, increasing cardiac output and heart rate
|
|
explain the mechanism of epinephrine treatment in shock victims (reference alpha and beta receptors)
|
A1 - vasoconstriction, decrease secretions and vascular permeability
B1 - cardiac output increases B2 - bronchodilation |
|
orthostatic hypotension, tachycardiarrythmias, and bloodshot eyes can all be treated with which class of drugs?
|
selective alpha 1 agonists
*stop taking the ortho'tension drug before sleep to avoid unecessary nocturnal TPR increase **A agonist for tachycardiaarrythmia relies on triggering the baroreceptor reflex |
|
alpha 2 agonists are not used clinically for peripheral effects, but they can act centrally in the treatment of ______ (name some of the drugs)
|
hypertension
clonidine/alpha-methyl-NE |
|
patients (especially the elderly) on alpha 1 antagonists are at risk of what common problem?
|
orthostatic hypotension
|
|
while arrythmia can be treated with an alpha agonist, it can also be treated with a selective beta ____ ____________
|
beta 1 antagonist
|
|
What is the mechanism underlying delaying of birth, slowing of peristalsis, and vasodilation via sympathetic stimulation?
|
beta muscle relaxation
|
|
Which step of bioamine synthesis is harnessed in Parkinson's treatment?
How is this treatment confined to the CNS? |
DOPA converted to Dopamine by DC (dopa decarboxylase) in the brain.
Confined to the CNS by a DC inhibitor that is unable to cross the BBB. |
|
What is the mechanism of action of indirect sympathomimetics (i.e. tyrinine, ephedrine, reserpine)?
What makes ephedrine unique? What are the two main differences between reserpine and tyrinine? |
Uptake into nerve terminals and into NT vesicles in lieu of NE; NE displaced into synaptic cleft.
Ephedrine is mixed action (also a B2 agonist). The speed/quality of uptake (reserpine is slower and irreversible) of drug into vesicles and which NTs can be displaced (reserpine works on all biogenic amines). |
|
Cocaine, Prozac, and Tricycline antidepressants mediate their effects by blocking the _____________ of biogenic amines at the ________.
|
Block uptake of biogenic amines at the nerve terminal.
Cocaine DA Tricycline 5-HT, NE SSRI 5-HT |
|
The enzyme _______ produces epinephrine by placing a ________ group on NE.
|
KMMT, methyl
|
|
Discuss two different measures taken to ensure that exogenously-administered DOPA is converted to DA in the brain.
|
1. Inhibit DOPA Decarboxylase (DC) with a drug that cannot cross the BBB.
2. Inhibit the catabolic enzyme COMT (kidneys/liver) so less DOPA gets shunted into a different pathway before reaching the brain. |
|
The biogenic amine degrading enzyme ______ comes in two forms, A and B. Inhibiting the A form can be particularly troublesome because it is responsible for the degradation of _____. The B form, on the other hand, is selective for the degradation of a single biogenic amine, _____.
|
MAOa degrades NE; MAO blockers coupled with excess NE transmission can lead to sympathetic overdrive.
The B form degrades DA (potential Parkinson's drug). |